Metformin, which is an insulin sensitizer, has been shown to ameliorate endothelial function with a significant association between endothelial function and insulin resistance following treatment in patients with type 2 diabetes mellitus [58]. The gene discussed is INS; the disease is type 2 diabetes mellitus.